Epilepsy Update

FACULTY:
Dr. Daniel Lapid, is a distinguished new member of the neurology team at the University of Texas Health Science Center. 

OVERVIEW:
In this episode, we dive deep into the advancements in pediatric epilepsy treatment, focusing on Responsive Neurostimulation (RNS) and its recent application in children. Dr. Lapid explains how this innovative device works, the conditions it treats, and its potential benefits for young patients with epilepsy. We also explore the crucial topic of infantile spasms, discussing their symptoms, diagnosis, and the importance of early intervention. Dr. Lapid provides valuable insights on the treatment options available, including the ketogenic diet, and shares a compelling case study to illustrate these points. Here’s more about Lennox-Gastaut syndrome.

OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers

DISCLOSURE TO LEARNERS:
Daniel Lapid, MD, has no financial relationships with ineligible companies to disclose.

The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Steven Seidner, MD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose.

The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.

CONTINUING MEDICAL EDUCATION STATEMENTS:
The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The UT Health Science Center San Antonio designates this live activity up to a maximum of 0.50 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.

Credit may be obtained upon successful completion of the activity’s evaluation.

RELEASE DATE:
8/30/2024 

EXPIRATION DATE:
8/31/2026